Showing results (441-450 of 506) with videos related to

Sort By:
Pageof 51
Antimicrobial Agents and Chemotherapy|April 29, 2015
Emergence of polymyxin B resistance influences pathogenicity in Pseudomonas aeruginosa mutatorsZackery P Bulman, Mark D Sutton, Neang S Ly, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1991
Dexamethasone/ifosfamide/cisplatin/etoposide (DICE) as therapy for patients with advanced refractory non-Hodgkin's lymphoma: preliminary report of a phase II studyP E Goss, F A Shepherd, J G Scott, et al.
European Journal of Cancer (Oxford, England : 1990)|October 14, 2008
Evaluation of the prognostic value of systemic inflammation and socioeconomic deprivation in patients with resectable colorectal liver metastasesC P Neal, C D Mann, C D Sutton, et al.
Journal of Bacteriology|December 4, 2012
Evolution in fast forward: a potential role for mutators in accelerating Staphylococcus aureus pathoadaptationGregory S Canfield, Johanna M Schwingel, Matthew H Foley, et al.
Biotechnology and Applied Biochemistry|June 1, 1989
Production of recombinant human serum albumin from Saccharomyces cerevisiaeA V Quirk, M J Geisow, J R Woodrow, et al.
International Journal of Antimicrobial Agents|June 30, 2024
PBP-3 directed therapy in VIM-producing Pseudomonas aeruginosa creates bacterial transformers, persisters in disguiseNicholas M Smith, Katie Rose Boissonneault, Patricia N Holden, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 3, 2007
Tumour characteristics predictive of survival following resection for ductal adenocarcinoma of the head of pancreasG Garcea, A R Dennison, S L Ong, et al.
Pageof 51